Expression of c-kit receptor in human cholangiocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice

Figure 1 c-kit protein expression in biliary tract cancer cell lines.

Figure 2 Immunocytochemistry in biliary tract cancer cell lines of Mz-ChA-2 (A), EGI-1 (B) and HT-29 (C).

Figure 3 c-kit protein expression in 12 (A), 5 (B) and 2 (C) human biliary tract cancer tissue samples (SABC x 200).

Figure 4 Inhibition of imatinib on cell growth (^aP < 0. 05).

Figure 5 In vivo treatment with imatinib mesilate in chimeric mice; A: effect on tumor volume and tumor mass (^aP < 0. 05, imatinib vs control); B: hematoxilin-eosin stained paraffin-embedded tissue sections.